AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
RESIDUAL DISEASE MONITORING IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA(CML) TREATED WITH INTERFERON-A BY MEANS OF INTERPHASE CYTOGENETICS AND COMPETITIVE RT-PCR
Authors: TCHIRKOV A GIOLLANT M BRIANCON G TRAVADE P TAVERNIER F TOURNILHAC O KWIATKOWSKI F CHOUFI B DEMEOCQ F MALET P
Citation: A. Tchirkov et al., RESIDUAL DISEASE MONITORING IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA(CML) TREATED WITH INTERFERON-A BY MEANS OF INTERPHASE CYTOGENETICS AND COMPETITIVE RT-PCR, European journal of human genetics, 6, 1998, pp. 6010-6010
SECONDARY ACUTE-LEUKEMIA IN CHRONIC LYMPHOCYTIC-LEUKEMIA - REPLY
Authors: DIGHIERO G TRAVADE P BINET JL
Citation: G. Dighiero et al., SECONDARY ACUTE-LEUKEMIA IN CHRONIC LYMPHOCYTIC-LEUKEMIA - REPLY, The New England journal of medicine, 339(13), 1998, pp. 924-924
CHLORAMBUCIL IN INDOLENT CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: DIGHIERO G MALOUM K DESABLENS B CAZIN B NAVARRO M LEBLAY R LEPORRIER M JAUBERT J LEPEU G DREYFUS B BINET JL TRAVADE P TURPIN FL TERTIAN G BICHOFFE A
Citation: G. Dighiero et al., CHLORAMBUCIL IN INDOLENT CHRONIC LYMPHOCYTIC-LEUKEMIA, The New England journal of medicine, 338(21), 1998, pp. 1506-1514
G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: HAROUSSEAU JL WITZ F LIOURE B LEPRISE PY SOLARY E ABGRALL JF CASSASUS P AUDHUY B TRAVADE P CAHN JY
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML), British Journal of Haematology, 102(1), 1998, pp. 86-86
EARLY USE OF CHLORAMBUCIL IS UNABLE TO INFLUENCE SURVIVAL IN STAGE-A CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS - LONG-TERM RESULTS FROM 2RANDOMIZED TRIALS OF THE FRENCH COOPERATIVE GROUP IN CLL
Authors: DIGHIERO G MALOUM K DESABLENS B CAZIN B NAVARRO M LEBLAY R LEPORRIER M JAUBERT J LEPEU G DREYFUS B TURPIN FL TERTIAN G BICHOFFE A BINET JL TRAVADE P
Citation: G. Dighiero et al., EARLY USE OF CHLORAMBUCIL IS UNABLE TO INFLUENCE SURVIVAL IN STAGE-A CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS - LONG-TERM RESULTS FROM 2RANDOMIZED TRIALS OF THE FRENCH COOPERATIVE GROUP IN CLL, British Journal of Haematology, 102(1), 1998, pp. 278-278
INTERPHASE CYTOGENETICS AND COMPETITIVE RT-PCR FOR RESIDUAL DISEASE MONITORING IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA DURING INTERFERON-ALPHA THERAPY
Authors: TCHIRKOV A GIOLLANT M TAVERNIER F BRIANCON G TOURNILHAC O KWIATKOWSKI F PHILIPPE P CHOUFI B DEMEOCQ F TRAVADE P MALET P
Citation: A. Tchirkov et al., INTERPHASE CYTOGENETICS AND COMPETITIVE RT-PCR FOR RESIDUAL DISEASE MONITORING IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA DURING INTERFERON-ALPHA THERAPY, British Journal of Haematology, 101(3), 1998, pp. 552-557
AUTOIMMUNE THROMBOCYTOPENIA AFTER 6 CYCLES OF FLUDARABINE PHOSPHATE IN A PATIENT WITH CHRONIC LYMPHOTIC LEUKEMIA
Authors: BAY JO FOUASSIER M BEAL D ALCARAZ L CURE H CHOLLET P PLAGNE R TRAVADE P
Citation: Jo. Bay et al., AUTOIMMUNE THROMBOCYTOPENIA AFTER 6 CYCLES OF FLUDARABINE PHOSPHATE IN A PATIENT WITH CHRONIC LYMPHOTIC LEUKEMIA, HEM CELL TH, 39(4), 1997, pp. 209-212
BILATERAL EYELID LOCALIZATION OF A LYMPHOPLASMACYTOID LYMPHOMA
Authors: FOUASSIER M MENERATH JM TAVERNIER F FOUILHOUX A KEMENY JL ROZAN R TRAVADE P
Citation: M. Fouassier et al., BILATERAL EYELID LOCALIZATION OF A LYMPHOPLASMACYTOID LYMPHOMA, Leukemia & lymphoma, 27(3-4), 1997, pp. 369
QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED BY INTERFERON USING INTERPHASE FISH AND COMPETITIVE RT-PCR
Authors: TCHIRKOV A GIOLLANT M BRIANCON G TRAVADE P TOURNILHAC O DEMEOCQ F KULESHOV N MALET P
Citation: A. Tchirkov et al., QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED BY INTERFERON USING INTERPHASE FISH AND COMPETITIVE RT-PCR, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 325-325
FEASIBILITY OF A PB CD34(+) CELL TRANSPLANTATION PROCEDURE USING STANDARD LEUKAPHERESIS PRODUCTS IN VERY SMALL CHILDREN
Authors: BERGER M KANOLD J RAPATEL C DELUMLEY L LUTZ P PLANTAZ D VANNIER JP MECHINAUD F BERGERON C FAVROT M GEMBARA P HALLEHAUSS P BONHOMME J TRAVADE P DEMEOCQ F
Citation: M. Berger et al., FEASIBILITY OF A PB CD34(+) CELL TRANSPLANTATION PROCEDURE USING STANDARD LEUKAPHERESIS PRODUCTS IN VERY SMALL CHILDREN, Bone marrow transplantation, 20(3), 1997, pp. 191-198
LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL
Authors: BRUGIATELLI M CLAISSE JF LENORMAND B MORABITO F CALLEA V MALLOUM K CHEVRET S BINET JL DIGHIERO G TRAVADE P
Citation: M. Brugiatelli et al., LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, British Journal of Haematology, 97(1), 1997, pp. 113-118
LARGE-VOLUME-LEUKAPHERESIS FOR PBPC COLLECTION IN CHILDREN WEIGHING LESS-THAN-OR-EQUAL-TO-15 KG
Authors: KANOLD J HALLE P BERGER M RAPATEL C DELUMLEY L VANNIER JP STEPHAN JL BERNARD F TRAVADE P DEMEOCQ F
Citation: J. Kanold et al., LARGE-VOLUME-LEUKAPHERESIS FOR PBPC COLLECTION IN CHILDREN WEIGHING LESS-THAN-OR-EQUAL-TO-15 KG, Blood, 90(10), 1997, pp. 4223-4223
ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL
Authors: FENAUX P CHASTANG C SANZ M THOMAS X DOMBRET H LINK H GUERCI A FEGUEUX N SANMIGUEL J RAYON C ZITTOUN R GARDIN C MALOISEL F FEY M TRAVADE P REIFFERS J STAMATOULAS A STOPPA AM CAILLOT D LEFRERE F HAYAT M CASTAIGNE S CHOMIENNE C DEGOS L
Citation: P. Fenaux et al., ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL, Blood, 90(10), 1997, pp. 533-533
RANDOMIZED COMPARISON OF FLUDARABINE, CAP AND CHOP, IN 695 PREVIOUSLYUNTREATED STAGE-B AND STAGE-C CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - EARLY STOPPING OF THE CAP ACCRUAL
Authors: LEPORRIER M CHEVRET S CAZIN B FEUGIER P RAPP MJ BOUDJERRA N AUTRAND C DREYFUS B DESABLENS B DIGHIERO G TRAVADE P CHASTANG C BINET JL
Citation: M. Leporrier et al., RANDOMIZED COMPARISON OF FLUDARABINE, CAP AND CHOP, IN 695 PREVIOUSLYUNTREATED STAGE-B AND STAGE-C CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - EARLY STOPPING OF THE CAP ACCRUAL, Blood, 90(10), 1997, pp. 2357-2357
THE DELAYED PLATELET RECOVERY FOLLOWING SELECTED PB CD34-MK NUMBER DURING IMMUNOSELECTION( CELLS TRANSPLANTATION IN CHILDREN IS PROBABLY DUE TO A QUANTITATIVE LOSS IN CFU)
Authors: FOUASSIER M BOIRET N RAPATEL C HALLE P KANOLD J BERGER J PIREYRE P BLANZAT V BONHOMME J TRAVADE P DEMEOCQ F BERGER M
Citation: M. Fouassier et al., THE DELAYED PLATELET RECOVERY FOLLOWING SELECTED PB CD34-MK NUMBER DURING IMMUNOSELECTION( CELLS TRANSPLANTATION IN CHILDREN IS PROBABLY DUE TO A QUANTITATIVE LOSS IN CFU), Blood, 90(10), 1997, pp. 2398-2398
DEFERRED VERSUS EARLY THERAPY WITH CHLORAMBUCIL IN STAGE A CLL PATIENTS - LONG-TERM RESULTS FROM 2 RANDOMIZED TRIALS OF THE FRENCH COOPERATIVE GROUP IN CLL
Authors: DIGHIERO G CHEVRET S PIGUET H MALOUM K DESABLENS B FENAUX P PIGNON B NAVARRO M LEBLAY R LEPORRIER M JAUBERT J COLOMBAT P VAUGIER G LEPEU G TURPIN F MEFFRE D CLAISSE JF CAZIN B BINET JL CHASTANG C TRAVADE P
Citation: G. Dighiero et al., DEFERRED VERSUS EARLY THERAPY WITH CHLORAMBUCIL IN STAGE A CLL PATIENTS - LONG-TERM RESULTS FROM 2 RANDOMIZED TRIALS OF THE FRENCH COOPERATIVE GROUP IN CLL, Blood, 90(10), 1997, pp. 2572-2572
RESIDUAL DISEASE MONITORING BY INTERPHASE CYTOGENETICS DURING INTERFERON TREATMENT OF CHRONIC MYELOID-LEUKEMIA
Authors: TCHIRKOV A GIOLLANT M BRIANCON G TRAVADE P TOURNILHAC O DEMEOCQ F MALET P
Citation: A. Tchirkov et al., RESIDUAL DISEASE MONITORING BY INTERPHASE CYTOGENETICS DURING INTERFERON TREATMENT OF CHRONIC MYELOID-LEUKEMIA, American journal of human genetics, 61(4), 1997, pp. 462-462
HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE
Authors: FLEURY J LEGROS M COLOMBAT P CURE H TRAVADE P TORTOCHAUX J DIONET C CHOLLET P LINASSIER C LAMAGNERE JP BLAISE D VIENS P MARANINCHI D PLAGNE R
Citation: J. Fleury et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE, Leukemia & lymphoma, 20(3-4), 1996, pp. 259-266
MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FENAUX P BINET JL LEPORRIER M TRAVADE P PIGUET H LINASSIER C DESABLENS B DREYFUS B BRIZARD CP MURGUE B RUSSET T SOUTEYRAND P JOHNSON S PHILLIPS MJ HIDDEMANN W SMITH A ROATH S LOFFLER H BJORKHOLM M OSBY E EMMERICH B COIFFIER B THIEL E KNAUF W JULIUSSON G MARCUS R PRENTICE AG COPPLESTONE JA FREUND M MILLIGAN PW WINFIELD D YIN J HELLRIEGEL KP HOSSFELD DK KIMBY E BURNETT AK LISTER TA LUCIE N KANZ L LERNER R LINDEMALM C CHILD A HAMBLIN T OSCIER D SMITH JG SINGER RJ PARKER A WHITTAKER J WYLD P SMITH AG
Citation: P. Fenaux et al., MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Lancet, 347(9013), 1996, pp. 1432-1438
TIMED SEQUENTIAL CHEMOTHERAPY FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF THE ETOPOSIDE, MITOXANTRONE, AND CYTARABINE-86 TRIAL
Authors: ARCHIMBAUD E THOMAS X LEBLOND V MICHALLET M FENAUX P CORDONNIER C DREYFUS F TROUSSARD X JAUBERT J TRAVADE P TRONCY J ASSOULINE D FIERE D
Citation: E. Archimbaud et al., TIMED SEQUENTIAL CHEMOTHERAPY FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF THE ETOPOSIDE, MITOXANTRONE, AND CYTARABINE-86 TRIAL, Journal of clinical oncology, 13(1), 1995, pp. 11-18
CD34(-CSF-ALONE-PRIMED PERIPHERAL-BLOOD IN CHILDREN WITH LOW BODY-MASS() CELL IMMUNOSELECTION FROM G)
Authors: KANOLD J BERGER M RAPATEL C DELUMLEY L LUTZ P PLANTAZ D VANNIER JP BERGERON C MECHINAUD F FAVROT M BONHOMME J TRAVADE P DEMEOCQ F
Citation: J. Kanold et al., CD34(-CSF-ALONE-PRIMED PERIPHERAL-BLOOD IN CHILDREN WITH LOW BODY-MASS() CELL IMMUNOSELECTION FROM G), British Journal of Haematology, 91(2), 1995, pp. 431-433
SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL
Authors: BRUGIATELLI M CLAISSE JF LENORMAND B MORABITO F CALLEA V MALLOUM K CHEVRET S BINET JL DIGHIERO G TRAVADE P
Citation: M. Brugiatelli et al., SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, Blood, 86(10), 1995, pp. 1377-1377
ROUTINE PERIPHERAL-BLOOD STEM-CELLS (PBSC) COLLECTION FOLLOWED BY CD34- BIOLOGICAL AND CLINICAL-RESULTS( CELL IMMUNOSELECTION IS POSSIBLE IN CHILDREN WEIGHING 20 KG OR LESS )
Authors: DEMEOCQ F KANOLD J BERGER M RAPATEL C DELUMLEY L LUTZ P PLANTAZ D VANNIER JP MECHINAUD F BERGERON C BONHOMME J TRAVADE P FAVROT M MALPUECH G
Citation: F. Demeocq et al., ROUTINE PERIPHERAL-BLOOD STEM-CELLS (PBSC) COLLECTION FOLLOWED BY CD34- BIOLOGICAL AND CLINICAL-RESULTS( CELL IMMUNOSELECTION IS POSSIBLE IN CHILDREN WEIGHING 20 KG OR LESS ), Blood, 86(10), 1995, pp. 1599-1599
CFU-GM, BFU-E AND CD34-BLOOD OF UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS( CELLS IN THE PERIPHERAL)
Authors: BERGER M RAPATEL C KANOLD J TAVERNIER F HAUSS P BONHOMME J DEMEOCQ F TRAVADE P
Citation: M. Berger et al., CFU-GM, BFU-E AND CD34-BLOOD OF UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS( CELLS IN THE PERIPHERAL), Blood, 86(10), 1995, pp. 3304-3304
THE HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN HODGKINS-DISEASE - QUESTIONS AND CONTROVERSIES
Authors: FLEURY J LEGROS M CURE H TORTOCHAUX J CONDAT P DIONET C TRAVADE P BELEMBAOGO E TAVERNIER F KWIATKOWSKI F CHOLLET P PLAGNE R
Citation: J. Fleury et al., THE HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN HODGKINS-DISEASE - QUESTIONS AND CONTROVERSIES, Leukemia & lymphoma, 15(5-6), 1994, pp. 419-432
Risultati: 1-25 | 26-40